Literature DB >> 8024793

Oligonucleotide design and optimized protocol for site-directed mutagenesis.

M P Piechocki1, R N Hines.   

Abstract

We have optimized conditions for the successful execution of site-directed mutagenesis (SDM) in systems that utilize mutagenic oligonucleotide primers to direct the synthesis of mutant plasmids. In this report, we describe strategies for the design of single-strand DNA templates for SDM, mutagenic oligonucleotide primers, as well as conditions for the annealing, synthesis and propagation of mutant plasmids. The primary focus of the report details the technical aspects of computer-assisted mutagenic oligonucleotide design. Important features include oligonucleotide length, number of matched bases flanking the point(s) of mutation(s), melting temperature, internal stability of the 5' and 3' ends, hairpin and dimer formation, and potential false-priming sites. Largely through a retrospective analysis of our successes and failures, we describe features of the mutagenic oligonucleotide primer that appear critical in this mutagenesis system. Specific examples of efficient and inefficient oligonucleotides are discussed. These characteristics and guidelines should be applicable for SDM of a broad range of target sequences of varying composition, complexity and secondary structure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024793

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  5 in total

1.  The use of site-directed mutagenesis, transient transfection, and radioligand binding. A method for the characterization of receptor-ligand interactions.

Authors:  J G Newell; M Davies; A N Bateson
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

2.  A method for introducing site-specific mutations using oligonucleotide primers and its application to site-saturation mutagenesis.

Authors:  M J O'Donohue; G G Kneale
Journal:  Mol Biotechnol       Date:  1996-10       Impact factor: 2.695

3.  Genetic analysis of second-site revertants of bacteriophage lambda integrase mutants.

Authors:  Z Wu; R I Gumport; J F Gardner
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

4.  Site-directed mutagenesis using positive antibiotic selection.

Authors:  R N Bohnsack
Journal:  Mol Biotechnol       Date:  1997-04       Impact factor: 2.695

5.  Partial characterization of the human CYP1A1 negatively acting transcription factor and mutational analysis of its cognate DNA recognition sequence.

Authors:  P D Boucher; M P Piechocki; R N Hines
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.